RECRUITING

Circuit-Based Deep Brain Stimulation for Parkinson's Disease P1A2&3 Catalyst

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will help us better understand how the brain works in people with Parkinson's disease (PD). PD is a brain disease that gets worse over time, and affects over 10 million people world-wide. A common treatment for PD is Deep Brain Stimulation (DBS). To improve DBS therapy for PD, we need a deeper understanding of how the different parts of the brain work together in PD, and how this relates to movement and thinking problems that people with PD experience. We may be able to use the results of this study to improve DBS treatments in the future.

Official Title

Circuit-Based Deep Brain Stimulation for Parkinson's Disease P1A2&3 Catalyst

Quick Facts

Study Start:2023-03-28
Study Completion:2027-03-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05658302

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of idiopathic PD
  2. * Surgery at UMN to implant DBS system with directional lead(s) and multiple independent current control IPG is planned as part of routine clinical care
  3. * At least 21 years old
  4. * Existing or planned 7T brain imagery
  1. * Other significant neurological disorder
  2. * History of dementia
  3. * Patients with post-operative complications or adverse effects (e.g. ON stimulation dystonias) that affect patient safety or confound the experiment will be excluded from further study
  4. * Pregnant women
  5. * Known radiation exposure within the last year that is determined to be unsafe when compounded with the expected radiation dose from intraoperative fluoroscopy to place ECoG strip

Contacts and Locations

Study Contact

Michael Park, PhD, MD
CONTACT
612-626-4706
mcpark@umn.edu

Study Locations (Sites)

University Of Minnesota
Minneapolis, Minnesota, 55445
United States

Collaborators and Investigators

Sponsor: University of Minnesota

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-03-28
Study Completion Date2027-03-01

Study Record Updates

Study Start Date2023-03-28
Study Completion Date2027-03-01

Terms related to this study

Additional Relevant MeSH Terms

  • Parkinson Disease